Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 1, 2008, Pages 187-195

  Zhong, Wenzhao ^a   Yang, Xuening ^a   Bai, Jianling ^b   Yang, Jinji ^a   Manegold, Christian ^c   Wu, Yilong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carcinoma; Combined modality therapy; Lymph node excision; Mediastinal lymph node; Neoplasm staging; Non small cell lung

Indexed keywords

ADVANCED CANCER; CANCER STAGING; DATA BASE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDIASTINUM LYMPH NODE; MEDLINE; PRIORITY JOURNAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDIASTINUM; NEOPLASM STAGING; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 45549092464     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.03.060     Document Type: Review

References (68)

1. Robinson L.A., Wagner Jr. H., and Ruckdeschel J.C. Treatment of stage IIIA non-small cell lung cancer. Chest 123 (2003) 202S-220S
2. Nohl H.C. An investigation into the lymphatic and vascular spread of carcinoma of the bronchus. Thorax 11 (1956) 172-185
3. Cahan W.G., Watson W.L., and Pool J.L. Radical pneumonectomy. J Thorac Surg 22 (1951) 449-473
4. Massard G., Ducrocq X., Kochetkova E.A., Porhanov V.A., and Riquet M. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur J Cardiothorac Surg 30 (2006) 164-167
5. Naruke T., Suemasu K., and Ishikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 71 (1976) 279-285
6. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 832-839
7. Martini N., Flehinger B.J., Zaman M.B., and Beattie Jr. E.J. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 198 (1983) 386-397
8. Martini N., Flehinger B.J., Zaman M.B., and Beattie Jr. E.J. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases. J Thorac Cardiovasc Surg 80 (1980) 390-399
9. Ishida T., Yano T., Maeda K., Kaneko S., Tateishi M., and Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 50 (1990) 708-713
10. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
11. Rusch V.W., Crowley J., Giroux D.J., Goldstraw P., Im J.G., Tsuboi M., Tsuchiya R., and Vansteenkiste J. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 603-612
12. Watanabe Y., Shimizu J., Tsubota M., and Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cancer. Chest 97 (1990) 1059-1065
13. Izbicki J.R., Passlick B., Hosch S.B., Kubuschock B., Schneider C., Busch C., Knoefel W.T., Thetter O., and Pantel K. Mode of spread in the early phase of lymphatic metastasis in non-small cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 112 (1996) 623-630
14. Graham A.N., Chan K.J., Pastorino U., and Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 117 (1999) 246-251
15. Massard G., Kochetkova E.A., Porhanov V.A., and Riquet M. Reply to Belcher and Goldstraw. Eur J Cardiothorac Surg 31 (2007) 143-144
16. Yoshimasu T., Miyoshi S., Oura S., Hirai I., Kokawa Y., and Okamura Y. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations. J Thorac Cardiovasc Surg 130 (2005) 433-437
17. Allen M.S. Mediastinal lymph node dissection for non-small cell lung cancer. J Thorac Cardiovasc Surg 130 (2005) 241-242
18. Belcher E., and Goldstraw P. Is radical mediastinal dissection mandatory for curative resection of NSCLC?. Eur J Cardiothorac Surg 31 (2007) 142-143
19. Lewis R.J. Is radical lymphadenectomy a valid oncologic procedure?. Eur J Cardiothorac Surg 16 Suppl. 1 (1999) S11-S12
20. Martini N. Mediastinal lymph node dissection for lung cancer. The Memorial experience. Chest Surg Clin N Am 5 (1995) 189-203
21. Rami-Porta R., Wittekind C., and Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 49 (2005) 25-33
22. Wu Y.-L., Huang Z.F., Wang S.Y., Yang X.N., and Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36 (2002) 1-6
23. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., and Ris H.-B. Morbidity, survival, and site of recurrence after mediastinal lymph node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 80 (2005) 268-275
24. Gajra A., Newman N., Gamble G.P., Kohman L.J., and Graziano S.L. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small cell lung cancer. J Clin Oncol 21 (2003) 1029-1034
25. Whitson B.A., Groth S.S., and Maddaus M.A. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 84 (2007) 1059-1065
26. Ludwig M.S., Goodman M., Miller D.L., and Johnstone P.A. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 128 (2005) 1545-1550
27. Watanabe S.-I., Ladas G., and Goldstraw P. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. Ann Thorac Surg 73 (2002) 245-248
28. Barnard J., Dunning J., Musleh G., and Odom N. Is there a role for the use of radical lymph node dissection in the surgical management of resectable non-small cell lung cancer?. Interact Cardiovasc Thoracic Surg 3 (2004) 294-299
29. Wright G., Manser R.L., Byrnes G., Hart D., and Campbell D.A. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax 61 (2006) 597-603
30. Passlick B., Kubuschock B., Sienel W., Thetter O., Pantel K., and Izbicki J.R. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study. Eur J Cardiothorac Surg 21 (2002) 520-526
31. Sugi K., Nawata K., Fujita N., Ueda K., Tanaka T., Matsuoka T., Kaneda Y., and Esato K. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 22 (1998) 290-294 [discussion 294-5]
32. Izbicki J.R., Passlick B., Pantel K., Pichlmeier U., Hosch S.B., Karg O., and Thetter O. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 227 (1998) 138-144
33. Izbicki J.R., Passlick B., Karg O., Bloechle C., Pantel K., Knoefel W.T., and Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 59 (1995) 209-214
34. Izbicki J.R., Thetter O., Habekost M., Karg O., Passlick B., Kubuschok B., Busch C., Haeussinger K., Knoefel W.T., Pantel K., and Schweiberer L. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 81 (1994) 229-235
35. Keller S.M., Adak S., Wagner H., Johnson D.H., and Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIA non-small cell lung cancer. Ann Thorac Surg 70 (2000) 358-365 [discussion 356-65]
36. Wright G.M. When in doubt should we cut it out? The role of surgery in non-small cell lung cancer. Thorax 62 (2007) 190-191 [author reply 191]
37. Allen M.S., Darling G.E., Pechet T.T., Mitchell J.D., Herndon II J.E., Landreneau R.J., Inculet R.I., Jones D.R., Meyers B.F., Harpole D.H., Putnam Jr. J.B., and Rusch V.W. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81 (2006) 1013-1019 [discussion 1019-20]
38. Ginsberg R.J., Rubinstein L.V., and Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60 (1995) 615-622 [discussion 613-22]
39. Pass HI, Carbone DP, Johnson DH, Minna JD, Turrisi AT. Lung cancer: principles and practice, 3rd ed. Lippincott Williams & Wilkins, 2005:373-86.
40. Scott W.J., Howington J., Feigenberg S., Movsas B., and Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest 132 (2007) 234S-242S
41. Yamanaka A., Hirai T., Takahashi A., and Konishi F. Analysis of lobar lymph node metastases around the bronchi of primary and nonprimary lobes in lung cancer: risk of remnant tumor at the root of the nonprimary lobes. Chest 121 (2002) 112-117
42. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
43. Pignon J.P., Tribodet H., Scagliotti G.V., Douillard J.Y., Shepherd F.A., Stephens R.J., Le Chevalier T., and on behalf of the LCG. Lung adjuvant cisplatin evaluation (LACE): a pooled analysis of five randomized clinical trials including 4584 patients. J Clin Oncol (Meet Abstr) 24 (2006) 7008
44. Pisters K.M.W., Evans W.K., Azzoli C.G., Kris M.G., Smith C.A., Desch C.E., Somerfield M.R., Brouwers M.C., Darling G., Ellis P.M., Gaspar L.E., Pass H.I., Spigel D.R., Strawn J.R., Ung Y.C., and Shepherd F.A. Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Guideline. J Clin Oncol 25 (2007) 5506-5518
45. Holty J.E., and Gould M.K. When in doubt should we cut it out? The role of surgery in non-small cell lung cancer. Thorax 61 (2006) 554-556
46. Scagliotti G.V., and Novello S. Current development of adjuvant treatment of non-small cell lung cancer. Clin Lung Cancer 6 Suppl. 2 (2004) S63-S70
47. Roth J.A., Atkinson E.N., Fossella F., Komaki R., Bernadette Ryan M., Putnam Jr. J.B., Lee J.S., Dhingra H., De Caro L., Chasen M., and Hong W.K. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
48. Rosell R., Gomez-Codina J., Camps C., Javier Sanchez J., Maestre J., Padilla J., Canto A., Abad A., and Roig J. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
49. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., Braun D., Breton J.L., Lemarie E., Gouva S., Paillot N., Brechot J.M., Janicot H., Lebas F.X., Terrioux P., Clavier J., Foucher P., Monchatre M., Coetmeur D., Level M.C., Leclerc P., Blanchon F., Rodier J.M., Thiberville L., Villeneuve A., Westeel V., and Chastang C. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
50. Nagai K., Tsuchiya R., Mori T., Tada H., Ichinose Y., Koike T., and Kato H. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg 125 (2003) 254-260
51. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 72 (2001) 885-888
52. Wu Y.-L., Gu L.-J., Weng Y.-M., Feng W.-N., and Cheng C. Neo-adjuvant chemotherapy with docetaxel plus carboplatin for non-small cell lung cancer. Ann Oncol 13 (2002) 140
53. Voltolini L., Luzzi L., Ghiribelli C., Paladini P., Di Bisceglie M., and Gotti G. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy. Eur J Cardiothorac Surg 20 (2001) 1106-1112
54. Betticher D.C., Hsu Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., Schmid R.A., Pless M., Habicht J., Roth A.D., Spiliopoulos A., Stahel R., Weder W., Stupp R., Egli F., Furrer M., Honegger H., Wernli M., Cerny T., and Ris H.B. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
55. Bueno R., Richards W.G., Swanson S.J., Jaklitsch M.T., Lukanich J.M., Mentzer S.J., and Sugarbaker D.J. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
56. Pisters K., Vallieres E., Bunn P., Crowley J., Ginsberg R., Ellis P., Meyers B., Marks R., Treat J., Gandara D., and Southwest Oncology Group. S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. J Clin Oncol 23 (2005) 7012
57. Scagliotti G.V. Preliminary results of Ch. E.S.T. A phase III study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages non-small cell lung cancer (NSCLC). J Clin Oncol 23 (2005) 7023
58. Wu Y.-L., Gu L.-J., Wang S.-Y., and Yang X.-N. Neoadjuvant chemotherapy for NSCLC: the south China experience. Proc Am Soc Clin Oncol 21 (2002) 2753
59. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-63.
60. Kim E.S., and Bosquee L. The importance of accurate lymph node staging in early and locally advanced non-small cell lung cancer: an update on available techniques. J Thorac Oncol 2 Suppl. 2 (2007) S59-S67
61. De Leyn P., Lardinois D., Van Schil P., Rami-Porta R., Passlick B., Zielinski M., Waller D., Lerut T., and Weder W. European trends in preoperative and intraoperative nodal staging: ESTS guidelines. J Thorac Oncol 2 (2007) 357-361
62. De Leyn P., Stroobants S., De Wever W., Lerut T., Coosemans W., Decker G., Nafteux P., Van Raemdonck D., Mortelmans L., Nackaerts K., and Vansteenkiste J. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 24 (2006) 3333-3339
63. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., Waller D.A., Lerut T., and Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32 (2007) 1-8
64. Swanson S.J., Herndon II J.E., D'Amico T.A., Demmy T.L., McKenna Jr. R.J., Green M.R., and Sugarbaker D.J. Video-assisted thoracic surgery lobectomy: Report of CALGB 39802. A prospective, multi-institution feasibility study. J Clin Oncol 25 (2007) 4993-4997
65. Tsunezuka Y., Sato H., Hiranuma C., Tsukioka T., Kodama T., Iwase T., Ohta Y., Oda M., and Watanabe G. Intrapulmonary lymph nodes detected by exploratory video-assisted thoracoscopic surgery: appearance of helical computed tomography. Ann Thorac Cardiovasc Surg 6 (2000) 369-372
66. Cerfolio R.J., Bryant A.S., and Eloubeidi M.A. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg 84 (2007) 940-945
67. Krasna M.J. Role of thoracoscopic lymph node staging for lung and esophageal cancer. Oncology (Williston Park) 10 (1996) 793-802 [discussion 804, 813-794]
68. Pramesh C.S., Kulkarni N.N., Mistry R.C., and Badwe R.A. Lymphadenectomy in cancer: time for a paradigm shift?. Lancet Oncol 7 (2006) 450-451